This is with reference to our prior intimation dated December 16, 2025, wherein we had informed the Exchange about the meeting of the Board of Directors of Dr Lalchandani Labs Limited ('the Company') scheduled to be held on Monday, December 22, 2025, inter alia, to consider and approve matters relating to the proposed Rights Issue, including fixation of the record date, issue price, entitlement ratio and other related terms.\r\nWe wish to inform you that the aforesaid Board Meeting scheduled to be held on December 22, 2025 has been deferred due to the non-receipt of In-Principle Approval from BSE Limited for the proposed Rights Issue.